Company / R&D per Share
Structure Therapeutics Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.27
FY2025
5-year range
$0.64 / $3.78
FY2022-FY2025
Trend
+84.1%
vs FY2024
Sector context
#135 of 208
Health Care
What the data says
At $1.27, Structure Therapeutics Inc.'s r&d per share ranks #135 of 208 in the Health Care sector. Improved from $0.64 to $1.27 over the past 2 years.
Based on SEC 10-K filings.
1.27 in FY2025 with a 3-year CAGR of -30.5%.
Improved from $0.64 to $1.27 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -30.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#135 of 208 in Health CareTop 65% of 208This company $1.27 Sector average $28.82
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 84.1% year-over-year.
- Ranks #135 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.27 | +84.1% |
| FY2024 | $0.69 | +8.3% |
| FY2023 | $0.64 | -83.2% |
| FY2022 | $3.78 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026